657 A combination treatment of bone marrow-derived CD141+dendritic cells and PD1/PD-L1 inhibitors for effective immunotherapy for solid tumors

• Jeong Seong Mun,
• SungYoon Cho,
• Youngjoo Jeon,
• Jisun Lim,
• Gawhan Lee,
• Sungeun Yun,
• Hyunsoo Kim

Affiliations

Jeong Seong Mun

1Pharmicell Co.,Ltd., Seoul, Republic of Korea

SungYoon Cho

1Pharmicell Co.,Ltd., Seoul, Republic of Korea

Youngjoo Jeon

2Kim’s Stem Cell Clinic, Seoul, Republic of Korea

Jisun Lim

2Kim’s Stem Cell Clinic, Seoul, Republic of Korea

Gawhan Lee

1Pharmicell Co.,Ltd., Seoul, Republic of Korea

Sungeun Yun

1Pharmicell Co.,Ltd., Seoul, Republic of Korea

Hyunsoo Kim

2Kim’s Stem Cell Clinic, Seoul, Republic of Korea